LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Dr. Sarah Reisinger, dsm-firmenich, appointed as new Chair of EuropaBio

28/06/2023

NEWS RELEASE

Brussels, 28 June 2023

Today, EuropaBio’s General Assembly confirmed the appointment of Dr. Sarah Reisinger as the new Chair of the association. Sarah Reisinger is the Chief Science & Research Officer at dsm-firmenich.

Commenting on her appointment, Sarah Reisinger highlighted: "I feel privileged to take on the Chair of EuropaBio. Biotechnology is at the heart of my career as a scientist. I am passionate about the benefits and breakthroughs it brings to areas such as healthcare, nutrition, personal care, and the broader bioeconomy, enabling renewable and sustainable solutions for the world. I’m looking forward to further championing the role of biotechnology for healthcare and industrial products and the critical role of biomanufacturing for Europe’s green transition. Innovation is vital to unlock the potential of biotechnology for the sustainable future of the planet and our quality of life. There’s so much we can achieve together to secure Europe’s role as a global leader!"

Dr Claire Skentelbery, Director General of EuropaBio added "We are delighted to welcome Sarah as the new Chair of EuropaBio, representing the future of next generation sustainable industry in Europe through the newly created dsm-firmenich. This comes at a pivotal time for European legislation in biotechnology and EuropaBio builds on the voice of its members to ensure that it leads the way for a modern Europe in the world."

Dr. Sarah Reisinger will take on the new role with immediate effect for a two-year mandate.

Dr. Sarah Reisinger, dsm-firmenich, appointed as new Chair of EuropaBio


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

18/09/2023

Genopole joins EuropaBio: French biotechnology on a global scale


Read more
11/08/2023

SwiftPharma launches ‘Changing the global paradigm for biomanufacturing in plants’ October 23, Rotterdam


Read more
31/07/2023

European Biotech Week: Showcasing the Transformative Power of Biotechnology


Read more

Important links

  • Genopole joins EuropaBio: French biotechnology on a global scale
  • Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
LOGO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies